E-Newsletter - September 2021
Spotlight on Alliance Members
NCI NCORP Honors Two Alliance Members
Two Alliance members have been recognized for outstanding service and contributions to the conduct of community-based cancer research and work in the area of health disparities at the 2021 NCORP Annual Meeting held virtually August 25-27.
Susan S. Tuttle, RN, CCRP, has been awarded the Dorothy Coleman Outstanding Administrator Award. Ms. Tuttle has more than 40 years of medical oncology research and 15-plus years of administrative experience. She has served as a CRP Liaison for several Alliance trials and provides thoughtful input on behalf of Clinical Research Professionals. She currently oversees administrative, financial, and human resources for the Southeast Clinical Oncology Research Consortium NCORP (SCOR) Operations Center, and is responsible for clinical trial implementation and quality assurance activities within 24 community sites for the Alliance research base. Her dedication to the field of cancer clinical trials is truly admirable. Many thanks for all her years of service and for being an excellent administrator.
Lucile Adams-Campbell, PhD, has been featured in the 2021 NCORP Annual Meeting's NCI 50th Anniversary Commemoration Video for Outstanding Service and Contributions to the Conduct of Health Disparities Research. Dr. Adams-Campbell is a cancer epidemiologist, Associate Director for Minority Health and Health Disparities Research, Senior Associate Dean for Community Outreach and Engagement, and Professor of Oncology at Lombardi Comprehensive Cancer Center at Georgetown University Medical Center. She has received numerous awards and honors for her decades of research and contributions to the area of health disparities, including election to the National Academy of Medicine and induction into the D.C. Hall of Fame. Recently, Dr. Adams-Campbell has been awarded the Joseph F. Fraumeni, Jr. Distinguished Achievement Award from the American Society of Preventive Oncology and named a 2021 Fellow at the American Association for Cancer Research Academy. Her areas of research focus on addressing health disparities, with emphasis on clinical trials and cancers that disproportionately impact minority and underserved populations, particularly African Americans, in the areas of obesity, metabolic syndrome, and energy balance. Dr. Adams-Campbell also serves as Chair of the Alliance Health Disparities Committee. Warmest regards for her recognition and continued contributions to this important field.
For other articles in this issue of the Alliance E-News newsletter, see below.
- Message From the Group Chair - Monica M. Bertagnolli, MD
- Registration Now Open - 2021 Alliance Fall Virtual Group Meeting
- Alliance Expresses Gratitude to Committee Chairs Ending Terms
- Alliance Welcomes New Committee Leaders
- NCI NCORP Honors Two Alliance Members
-
Spotlight on Alliance Trials
Ten Currently Active Alliance Cancer Control Program/NCORP Research Base Trials
Alliance A171901 - Lung Cancer
Alliance A191901 - Endocrine Therapy Adherence
Alliance A211102 - Testing for Atypia
Alliance A211601 - Mammographic Breast Density
Alliance A221702 - Axillary Reverse Mapping
Alliance A221805 - Peripheral Neuropathy
Alliance A222001 - Reducing Hot Flashes in Men
Alliance A231601CD - Improving Surgical Care/Outcomes (OPIT-Surg)
Alliance A231701CD - Shared Breast Cancer Surgery Decision Making
Alliance A231901CD - Patient-Centered Communication in Breast Cancer
Four Recently Activated Alliance NCTN Trials
Alliance A021901 - Bronchial Neuroendocrine Tumors
Alliance A051902 - Peripheral T-cell Lymphoma
Alliance A031902 - Metastatic Castration-Resistance Prostate Cancer (CASPAR)
Alliance A011801 - HER2-Positive Breast Cancer (CompassHER2)
Closed to Accrual: Alliance A221505 (RT CHARM) -
Alliance Funding Opportunities
Daniel J. Sargent, PhD Memorial Fellowship in Innovative Clinical Trial Design and Methods Award -
Alliance in the News
Patient Perspective in Clinical Trials – Alliance Patient Advocate Julie Krause Interview
Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial
Patient Perspective on Clinical Trials - Alliance Patient Advocate Julie Krause
Impact of the COVID-19 Pandemic on Clinical Trials
Combining Tumor Deposits with the Number of Lymph Node Metastases to Improve the Prognostic Accuracy in Stage III Colon Cancer: A Post Hoc Analysis of the CALGB/SWOG 80702 Phase III Study (Alliance)
New ECU, Vidant Partnership Provides Access to Clinical Trials for Rare Cancers
Celecoxib Provides No Survival Benefit for Patients with Stage III Colon Cancer
Disparities in Older Adult Accrual to Cancer Trials: Analysis from the Alliance for Clinical Trials in Oncology (A151736)